Ibex Investors’s CONMED CNMD Stock Holding History

Ibex Investors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,807	Closed	-$304K	–	174
2018 Q1	$304K	Buy	+4,807	New	+$287K	0.25%	88

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ibex Investors's CNMD Position: Q2 2018 in Review

Ibex Investors sold out of CONMED (CNMD) in Q2 2018, closing a stake of 4,807 shares — an estimated $304K sold.

Ibex Investors first reported a position in CNMD in Q1 2018 and held it in 1 quarter. The position peaked at $304K in Q1 2018. 196 funds tracked by Wall St. Rank hold CNMD as of Q2 2018.

Ibex Investors reported no remaining CONMED position as of Q2 2018 after selling out during the quarter.
Ibex Investors sold 4,807 CONMED shares in Q2 2018, an estimated $304K.
Ibex Investors first reported a position in CONMED in Q1 2018 and held it in 1 quarter.
Ibex Investors's CONMED position peaked at $304K in Q1 2018.
196 funds tracked by Wall St. Rank held CONMED as of Q2 2018.

Based on Ibex Investors's 13F filing for Q2 2018, filed 14 Aug 2018.